BRPI0519622A2 - composiÇço farmacÊutica de polÍmero para distribuiÇço de liberaÇço controlada por via oral de sulfato de terbutalina - Google Patents
composiÇço farmacÊutica de polÍmero para distribuiÇço de liberaÇço controlada por via oral de sulfato de terbutalinaInfo
- Publication number
- BRPI0519622A2 BRPI0519622A2 BRPI0519622-1A BRPI0519622A BRPI0519622A2 BR PI0519622 A2 BRPI0519622 A2 BR PI0519622A2 BR PI0519622 A BRPI0519622 A BR PI0519622A BR PI0519622 A2 BRPI0519622 A2 BR PI0519622A2
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- polymer
- controlled release
- derivative
- release delivery
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 229920000642 polymer Polymers 0.000 title abstract 3
- KFVSLSTULZVNPG-UHFFFAOYSA-N terbutaline sulfate Chemical compound [O-]S([O-])(=O)=O.CC(C)(C)[NH2+]CC(O)C1=CC(O)=CC(O)=C1.CC(C)(C)[NH2+]CC(O)C1=CC(O)=CC(O)=C1 KFVSLSTULZVNPG-UHFFFAOYSA-N 0.000 title abstract 3
- 238000013270 controlled release Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 5
- 229920001661 Chitosan Polymers 0.000 abstract 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 abstract 2
- 239000011159 matrix material Substances 0.000 abstract 2
- 229960005105 terbutaline sulfate Drugs 0.000 abstract 2
- 229920001285 xanthan gum Polymers 0.000 abstract 2
- 229940082509 xanthan gum Drugs 0.000 abstract 2
- 235000010493 xanthan gum Nutrition 0.000 abstract 2
- 239000000230 xanthan gum Substances 0.000 abstract 2
- XWTYSIMOBUGWOL-UHFFFAOYSA-N (+-)-Terbutaline Chemical compound CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1 XWTYSIMOBUGWOL-UHFFFAOYSA-N 0.000 abstract 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000004676 glycans Chemical class 0.000 abstract 1
- 229920001282 polysaccharide Polymers 0.000 abstract 1
- 239000005017 polysaccharide Substances 0.000 abstract 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 abstract 1
- 235000017557 sodium bicarbonate Nutrition 0.000 abstract 1
- 229910021653 sulphate ion Inorganic materials 0.000 abstract 1
- 230000009897 systematic effect Effects 0.000 abstract 1
- 229960000195 terbutaline Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
COMPOSIÇçO FARMACÊUTICA DE POLÍMERO PARA DISTRIBUIÇçO DE LIBERAÇçO CONTROLADA POR VIA ORAL DE SULFATO DE TERBUTALINA. A presente invenção refere-se a uma composição farmacêutica de liberação controlada que proporciona distribuição sistemática do fármaco básico sulfato de terbutalina, a referida composição compreendendo pelo menos sulfato de terbutalina ou um derivado do mesmo como agente ativo, e compreendendo ainda uma matriz inativa, a referida matriz compreendendo uma mistura de polímeros polissacarídicos hidrófilos, a referida mistura compreendendo quitosano ou um derivado do mesmo, e compreendendo ainda goma xantana ou um derivado da mesma, onde a proporção de goma xantana e quitosano na referida mistura varia na faixa de cerca de 1:10 a cerca de 10:1, e a referida composição opcionalmente compreendendo bicarbonato de sódio.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05000985A EP1685831B1 (en) | 2005-01-19 | 2005-01-19 | Pharmaceutical polymer composition for oral controlled release delivery of terbutaline sulfate |
| PCT/EP2005/013530 WO2006076951A1 (en) | 2005-01-19 | 2005-12-29 | Pharmaceutical polymer composition for oral controlled-release delivery of terbutaline sulfate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0519622A2 true BRPI0519622A2 (pt) | 2009-02-25 |
Family
ID=34933362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0519622-1A BRPI0519622A2 (pt) | 2005-01-19 | 2005-12-29 | composiÇço farmacÊutica de polÍmero para distribuiÇço de liberaÇço controlada por via oral de sulfato de terbutalina |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20080206334A1 (pt) |
| EP (2) | EP1685831B1 (pt) |
| KR (1) | KR20070100364A (pt) |
| CN (1) | CN101102756A (pt) |
| AT (1) | ATE355833T1 (pt) |
| BR (1) | BRPI0519622A2 (pt) |
| CA (1) | CA2592269A1 (pt) |
| DE (1) | DE602005000675T2 (pt) |
| EA (1) | EA013969B1 (pt) |
| ES (1) | ES2284088T3 (pt) |
| NO (1) | NO20073850L (pt) |
| WO (1) | WO2006076951A1 (pt) |
| ZA (1) | ZA200705660B (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110064806A1 (en) * | 2009-09-11 | 2011-03-17 | Transtech Pharma, Inc. | Solid compositions comprising an oxadiazoanthracene compound and methods of making and using the same |
| CN102188399B (zh) * | 2011-04-02 | 2012-12-12 | 南京正科制药有限公司 | 托拉塞米胃漂浮片及其制备方法 |
| CN110057932B (zh) * | 2019-04-22 | 2022-03-15 | 上海旭东海普药业有限公司 | 高效液相色谱分析硫酸特布他林有关物质的方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3686275T2 (de) * | 1985-01-11 | 1993-03-18 | Teijin Ltd | Praeparate mit verzoegerter freisetzung. |
| US5620706A (en) * | 1995-04-10 | 1997-04-15 | Universite De Sherbrooke | Polyionic insoluble hydrogels comprising xanthan and chitosan |
-
2005
- 2005-01-19 DE DE602005000675T patent/DE602005000675T2/de not_active Expired - Lifetime
- 2005-01-19 EP EP05000985A patent/EP1685831B1/en not_active Expired - Lifetime
- 2005-01-19 ES ES05000985T patent/ES2284088T3/es not_active Expired - Lifetime
- 2005-01-19 AT AT05000985T patent/ATE355833T1/de not_active IP Right Cessation
- 2005-12-29 BR BRPI0519622-1A patent/BRPI0519622A2/pt not_active IP Right Cessation
- 2005-12-29 EP EP05820497A patent/EP1838299A1/en not_active Withdrawn
- 2005-12-29 CA CA002592269A patent/CA2592269A1/en not_active Abandoned
- 2005-12-29 ZA ZA200705660A patent/ZA200705660B/xx unknown
- 2005-12-29 CN CNA2005800468260A patent/CN101102756A/zh active Pending
- 2005-12-29 WO PCT/EP2005/013530 patent/WO2006076951A1/en not_active Ceased
- 2005-12-29 EA EA200701525A patent/EA013969B1/ru not_active IP Right Cessation
- 2005-12-29 US US11/813,301 patent/US20080206334A1/en not_active Abandoned
- 2005-12-29 KR KR1020077018762A patent/KR20070100364A/ko not_active Ceased
-
2007
- 2007-07-23 NO NO20073850A patent/NO20073850L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20073850L (no) | 2007-10-10 |
| CN101102756A (zh) | 2008-01-09 |
| DE602005000675T2 (de) | 2007-11-15 |
| EA200701525A1 (ru) | 2008-02-28 |
| EP1838299A1 (en) | 2007-10-03 |
| KR20070100364A (ko) | 2007-10-10 |
| DE602005000675D1 (de) | 2007-04-19 |
| US20080206334A1 (en) | 2008-08-28 |
| EP1685831A1 (en) | 2006-08-02 |
| EA013969B1 (ru) | 2010-08-30 |
| WO2006076951A1 (en) | 2006-07-27 |
| ZA200705660B (en) | 2009-01-28 |
| ES2284088T3 (es) | 2007-11-01 |
| EP1685831B1 (en) | 2007-03-07 |
| ATE355833T1 (de) | 2007-03-15 |
| CA2592269A1 (en) | 2006-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0806863B8 (pt) | uso de um éster de forbol na preparação de um medicamento para prevenção ou tratamento de uma infecção por hiv | |
| BR112014011841A2 (pt) | material de entrega de fármacos hidrofóbicos, método para a produção do mesmo e métodos para a entrega de uma composição de entrega de fármacos | |
| PE20061449A1 (es) | Composiciones farmaceuticas comprendiendo imatinib y un retardador de liberacion | |
| BRPI0718176B8 (pt) | formulação semissólida de liberação prolongada e controlada, processo para a preparação da composição farmacêutica semissólida | |
| BRPI0905369B8 (pt) | composição farmacêutica, uso da composição farmacêutica e kit compartimentado | |
| BRPI0518101A (pt) | métodos de produção e sìntese de composições nanoparticuladas, composições obtidas e seu uso | |
| BRPI0613401B8 (pt) | composição oftálmica compreendendo derivados de glicocorticoides que penetram seletivamente nos tecidos do segmento posterior | |
| CL2007003356A1 (es) | Compuestos derivados de benzopirazoles; proceso para la preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos y otro agente activo; y su uso para el tratamiento del asma, inflamacion, entre otras enfermedades. | |
| BRPI0807285A2 (pt) | "composição, método para preparar composição farmacêutica, forma unitária de dosagem, método para admnistrar um agente biologicamente ativo a um animal necessitando o agente, método para aumentar a biodisponibilidade de um agente biologicamente ativo, método para preparar uma composição e composto" | |
| UY30215A1 (es) | Derivados de cromanol sustituidos, procedimientos para su preparacion, composiciones farmacéuticas que los contienen y aplicaciones | |
| WO2008063768A3 (en) | Compositions and methods for treating metabolic diseases | |
| MX2010004373A (es) | Materiales miscibles en agua no acuosos como vehiculos para suministro de farmacos. | |
| CL2004000899A1 (es) | Composicion farmaceutica que contiene la sal sodica de telmisartan y un agente diuretico y procedimiento de preparacion. | |
| NO20082047L (no) | Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme | |
| ATE476997T1 (de) | Zusammensetzung und dosierform mit einer festen oder halbfesten matrix | |
| BRPI0519622A2 (pt) | composiÇço farmacÊutica de polÍmero para distribuiÇço de liberaÇço controlada por via oral de sulfato de terbutalina | |
| WO2004078111A3 (en) | Extended release minocycline compositions and processes for their preparation | |
| NO20082848L (no) | Farmasoytisk formulering for behandling av osteoartritt inneholdende klodronsyre og hyaluronsyre | |
| PE20061245A1 (es) | Composiciones para la transmision transmucosa oral de la metformina | |
| WO2007017331A3 (en) | Immediate release therapeutic systems for improved oral absorption of 7- [ (e) -tert-butyloxyiminomethyl] camptothecin | |
| WO2008138089A3 (en) | Pharmaceutical composition comprising a local anaesthetic and a carboxyvinyl polymer | |
| ATE390127T1 (de) | Universelle zusammensetzung zur kontrollierten wirkstoffabgabe enthaltend chitosan | |
| BRPI0409918A (pt) | composição farmacêutica na forma de um hidrogel para administração transdérmica de ingredientes ativos | |
| BRPI0506630A (pt) | composição de liberação controlada e método para administrar um medicamento aquoso transmucosal de liberação controlada | |
| Zhou et al. | Research progress of hydrogel therapy to improve hypoxic environment of periodontal tissues and promote periodontal regeneration |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 4A, 5A E 6A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE AS 4A, 5A E 6A ANUIDADES. |